Maj Invest
Edit

Maj Invest

https://www.majinvest.com/
Last activity: 25.08.2026
Active
Maj Invest
Portfolio
6
Mentions
39
Investment Stage: Series C

Portfolio 6

DateNameWebsiteTotal RaisedLocation
25.08.2026Alice AIalice.tech$4.76MUnited Sta...
27.10.2025Hemab Ther...hemab.com$347MUnited Sta...
26.08.2025Twin Healt...twinhealth.com$193MUnited Sta...
21.08.2025TWIN HEALT...usa.twinhealth.com$245MUnited Sta...
18.08.2025Dropla Tec...dropla.tech$2.81MDenmark
11.06.2025FlexiLoansflexiloans.com$214.98MIndia, Mah...

Mentions in press and media 39

DateTitleDescription
25.08.2026Alice Raises $140 Million As AI Security Business Approaches $100 Million ARR And Grows 500%+Alice (formerly known as ActiveFence) has raised $140 million in a funding round led by Apax Digital as the AI trust, safety and security company approaches $100 million in annual recurring revenue and expands its work with major frontier m...
09.07.2026MITS Capital Invests In Dropla Tech To Scale Edge-AI Defense Systems And Unmanned Ground VehiclesMITS Capital announced an investment in Dropla Tech, a Danish-Ukrainian defense technology company that develops edge-AI explosive-threat detection systems and unmanned ground vehicles (UGVs). Financial terms of the investment, including th...
16.06.2026CEO of Vestas Wind Systems appointed new Vice Chair of Bunker HoldingCEO of Vestas Wind Systems appointed new Vice Chair of Bunker Holding Tue, Jun 16, 2026 12:36 CET Report this content Danish USTC Group has appointed Henrik Andersen as new Vice Chair of subsidiary company Bunker Holding’s Board of Director...
19.04.2026Subra: €40 Million Raised To Build European Superconductor Champion With THEVA AcquisitionSubra has raised €40 million in a Series A funding round to accelerate its push to become a leading European force in superconducting technologies, while simultaneously acquiring long-time partner THEVA to expand its manufacturing and techn...
28.10.2025Hemab Therapeutics Secures $157M for Breakthrough Bleeding Disorder TherapiesHemab Therapeutics closed a $157 million Series C funding round. The clinical-stage biotechnology firm targets severe, underserved bleeding and thrombotic disorders. This significant capital influx will accelerate two flagship programs: HMB...
27.10.2025Hemab Therapeutics Raises $157M in Series C FinancingHemab Therapeutics, a Cambridge, MA, and Copenhagen, Denmark-based clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, closed a $157m Series C financing...
27.10.2025Hemab Therapeutics: $157 Million Series C Secured For Advancing Treatments For Underserved Bleeding DisordersHemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious bleeding and thrombotic disorders, announced that it has completed a $157 million Series C financing. The oversubscribed fundi...
22.10.2025Amicus-backed Berar Finance raises $17 mn; new investors enter captable(Photo by Jakub Zerdzicki: from Pexels) Nagpur-headquartered non-banking lender Berar Finance has raised Rs 150 crore (around $17 million) led by Norwegian Fund Abler Nordic, along with participation from First Bridge India Growth Fund, acc...
26.08.2025Twin Health: $53 Million Raised To Transform Metabolic Care With AI Digital TwinsTwin Health, a metabolic health technology company, has raised $53 million in new funding led by Denmark’s Maj Invest. This fresh investment aims to propel the company’s growth into Fortune 500 enterprises and health plans across diverse se...
22.08.2025CEE Startup & Tech Weekly: Big Bets, Bigger ValuationsCentral and Eastern Europe ~ Company: The Recursive’s weekly roundup aims to cover key tech developments across Central and Eastern Europe, as well as the growing impact of CEE-born founders on the global stage. Take a look at the latest ne...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In